We are currently seeking individuals to participate in our clinical studies. Study participants will receive study medication, study-related procedures at no cost and may also receive compensation for time and travel.
Please check back regularly for potential studies which may be of interest to you. You can also give us at call at 316-425-6333 to inquire about our studies or register online.
The ELARIS EM-COC study is evaluating the safety and effectiveness of an oral investigational medication when taken together with a combined oral contraceptive that contains estrogen and progesterone, in premenopausal women that are experiencing endometriosis pain.
If you’re living with Overactive Bladder (OAB) and haven’t had lasting success with medications, you may qualify for the TRANSFORM Trial. The study is for the Hologic Trigone Radiofrequency (RF) Device – an investigational device designed to reduce urinary leakage and improve bladder function
The Skylight Study is a clinical study evaluating the safety and effectiveness of a once-daily, nonhormonal investigational drug (fezolinetant) to see if it helps reduce the frequency and severity of hot flashes associated with menopause.
The Edelweiss study is a clinical trial to assess the safety and effectiveness of an investigational drug alone and in combination with hormonal add-back therapy compared to placebo in women with moderate to severe pain associated with endometriosis
This study is a clinical trial to investigate the effects of an extended release vaginal ring to reduce moderate to severe endometriosis-related pain.